Multiple physical healthcare needs among outpatients with schizophrenia: findings from a health examination study

References

• Smith DJ, Langan J, McLean G, Guthrie B, Mercer SW. Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: Cross-sectional study. BMJ Open 2013;3:e002808.
   PubMed Web of Science ®Google Scholar
• Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: A Swedish national cohort study. Am J Psychiatry 2013;170:324–33.
   PubMed Web of Science ®Google Scholar
• Nordentoft M, Wahlbeck K, Hallgren J, Westman J, Ösby U, Alinaghizadeh H, et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One 2013;8:e55176.
   PubMed Web of Science ®Google Scholar
• Crawford MJ, Jayakumar S, Lemmey SJ, Zalewska K, Patel MX, Cooper SJ, et al. Assessment and treatment of physical health problems among people with schizophrenia: National cross-sectional study. Br J Psychiatry 2014;205:473–7.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Malone D, Doebbeling CC. Quality of medical care for people with and without comorbid mental illness and substance misuse: Systematic review of comparative studies. Br J Psychiatry 2009;194:491–9.
   PubMed Web of Science ®Google Scholar
• De Hert M, Vancampfort D, Correll CU, Mercken V, Peuskens J, Sweers K, et al. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: Systematic evaluation. Br J Psychiatry 2011;199:99–105.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: Prevention and management. Nice Clinical Guideline 178; 2014. p. 594.
   Google Scholar
• Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: A review of the literature. Acta Psychiatr Scand 2007;116:317–33.
   PubMed Web of Science ®Google Scholar
• Oud MJ, Meyboom-de Jong B. Somatic diseases in patients with schizophrenia in general practice: Their prevalence and health care. BMC Fam Pract 2009;10:32.
   PubMed Web of Science ®Google Scholar
• De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011;10:52–77.
   PubMed Web of Science ®Google Scholar
• Honig A, Pop P, Tan ES, Philipsen H, Romme MAJ. Physical illness in chronic psychiatric patients from a community psychiatric unit. The implications for daily practice. Br J Psychiatry 1989;155:58–64.
   PubMed Web of Science ®Google Scholar
• De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011;10:138–51.
   PubMed Web of Science ®Google Scholar
• Stubbs B, Thompson T, Acaster S, Vancampfort D, Gaughran F, Correll CU. Decreased pain sensitivity among people with schizophrenia: A meta-analysis of experimental pain induction studies. Pain 2015;156:2121–31.
   PubMed Web of Science ®Google Scholar
• Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015;14:119–36.
   PubMed Web of Science ®Google Scholar
• Viertiö S, Tuulio-Henriksson A, Perälä J, Saarni SI, Koskinen S, Sihvonen M, et al. Activities of daily living, social functioning and their determinants in persons with psychotic disorder. Eur Psychiatry 2012;27:409–15.
   PubMed Web of Science ®Google Scholar
• Viertiö S, Sainio P, Koskinen S, Perälä J, Saarni SI, Sihvonen M, et al. Mobility limitations in persons with psychotic disorder: Findings from a population-based survey. Soc Psychiatry Psychiatr Epidemiol 2009;44:325–32.
   PubMed Web of Science ®Google Scholar
• Heistaro S. Health 2000 Survey. Methodology Report. Helsinki: National Public Health Institute, Finland, Department of Health and Functional Capacity; 2008.
   Google Scholar
• Eskelinen S, Sailas E, Joutsenniemi K, Holi M, Suvisaari J. Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia. Nord J Psychiatry 2015;69:339–45.
   PubMed Web of Science ®Google Scholar
• Virtanen T, Eskelinen S, Sailas E, Suvisaari J. Dyspepsia and constipation in patients with schizophrenia spectrum disorders. Nord J Psychiatry 2017;71:48–54.
   PubMed Web of Science ®Google Scholar
• Kestilä L, Koskinen S, Martelin T, Rahkonen O, Pensola T, Pirkola S, et al. Influence of parental education, childhood adversities, and current living conditions on daily smoking in early adulthood. Eur J Public Health 2006;16:617–26.
   PubMed Web of Science ®Google Scholar
• Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007;31:1208–17.
   PubMed Web of Science ®Google Scholar
• Wilhelmsen L, Tibblin G, Werko L. A primary preventive study of Gothenburg, Sweden. Prev Med 1972;1:153–60.
   PubMedGoogle Scholar
• Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of Adl: A standardized measure of biological and psychosocial function. JAMA 1963;185:914–9.
   PubMed Web of Science ®Google Scholar
• Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–86.
   PubMed Web of Science ®Google Scholar
• Tolonen H. EHES Manual. Part B. Fieldwork Procedures. Helsinki: National Institute of Health and Welfare; 2013. Available from: http://urn.fi/URN:ISBN:978-952-245-843-8.
   Google Scholar
• WONCA ICC. International Classification of Primary Care ICPC-2 R. Rev. 2nd ed. New York: Oxford University Press Inc; 2005.
   Google Scholar
• Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: Skin physiology and skin manifestations of obesity. J Am Acad Dermatol 2007;56:901–16.
   PubMed Web of Science ®Google Scholar
• Bruins J, Jorg F, Bruggeman R, Slooff C, Corpeleijn E, Pijnenborg M. The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysis. PLoS One 2014;9:e112276.
   PubMed Web of Science ®Google Scholar
• Curtis J, Watkins A, Rosenbaum S, Teasdale S, Kalucy M, Samaras K, et al. Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis. Early Interv Psychiatry 2016;10:267–76.
   PubMed Web of Science ®Google Scholar
• Ochner CN, Tsai AG, Kushner RF, Wadden TA. Treating obesity seriously: When recommendations for lifestyle change confront biological adaptations. Lancet Diabetes Endocrinol 2015;3:232–4.
   PubMed Web of Science ®Google Scholar
• Forey BA, Thornton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med 2011;11:36.
   PubMed Web of Science ®Google Scholar
• Urrutia I, Capelastegui A, Quintana JM, Muñiozguren N, Basagana X, Sunyer J, et al. Smoking habit, respiratory symptoms and lung function in young adults. Eur J Public Health 2005;15:160–5.
   PubMed Web of Science ®Google Scholar
• Saulyte J, Regueira C, Montes-Martinez A, Khudyakov P, Takkouche B. Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermatitis, and food allergy in adults and children: A systematic review and meta-analysis. PLoS Med 2014;11:e1001611.
   PubMed Web of Science ®Google Scholar
• Cohen D, Bogers JP, van Dijk D, Bakker B, Schulte PF. Beyond white blood cell monitoring: Screening in the initial phase of clozapine therapy. J Clin Psychiatry 2012;73:1307–12.
   PubMed Web of Science ®Google Scholar
• Nielsen J, Correll CU, Manu P, Kane JM. Termination of clozapine treatment due to medical reasons: When is it warranted and how can it be avoided? J Clin Psychiatry 2013;74:603–13.
   PubMed Web of Science ®Google Scholar
• Shirazi A, Stubbs B, Gomez L, Moore S, Gaughran F, Flanagan RJ, et al. Prevalence and predictors of clozapine-associated constipation: A systematic review and meta-analysis. Int J Mol Sci 2016;17:pii:E863.
   Web of Science ®Google Scholar
• Abel KM, Drake R, Goldstein JM. Sex differences in schizophrenia. Int Rev Psychiatry 2010;22:417–28.
   PubMed Web of Science ®Google Scholar
• Bergh S, Hjorthoj C, Sorensen HJ, Fagerlund B, Austin S, Secher RG, et al. Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10 years after baseline: The OPUS study. Schizophr Res 2016;175:57–63.
   PubMed Web of Science ®Google Scholar
• Suvisaari J, Perälä J, Saarni SI, Härkänen T, Pirkola S, Joukamaa M, et al. Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey. Eur Arch Psychiatry Clin Neurosci 2008;258:129–36.
   PubMed Web of Science ®Google Scholar
• Partti K, Vasankari T, Kanervisto M, Perälä J, Saarni SI, Jousilahti P, et al. Lung function and respiratory diseases in people with psychosis: Population-based study. Br J Psychiatry 2015;207:37–45.
   PubMed Web of Science ®Google Scholar
• Kaarne T, Aalto M, Kuokkanen M, Seppa K. AUDIT-C, AUDIT-3 and AUDIT-QF in screening risky drinking among Finnish occupational health-care patients. Drug Alcohol Rev 2010;29:563–7.
   PubMed Web of Science ®Google Scholar
• Borodulin K, Vartiainen E, Peltonen M, Jousilahti P, Juolevi A, Laatikainen T, et al. Forty-year trends in cardiovascular risk factors in Finland. Eur J Public Health 2015;25:539–46.
   PubMed Web of Science ®Google Scholar
• Sveinsson O, Thorleifsson K, Aspelund T, Kolbeinsson H. A study of risk factors for cardiovascular disease among schizophrenic patients using the rehabilitation mental health services at Kleppur. Laeknabladid 2012;98:399–402. [Icelandic].
   PubMed Web of Science ®Google Scholar
• Jousilahti P, Laatikainen T, Peltonen M, Borodulin K, Männisto S, Jula A, et al. Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: Population based observational study. BMJ 2016;352:i721.
   PubMed Web of Science ®Google Scholar
• Moore S, Shiers D, Daly B, Mitchell AJ, Gaughran F. Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care. Acta Psychiatr Scand 2015;132:109–21.
   PubMed Web of Science ®Google Scholar